• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    ImmunoGen, Inc. (IMGN)

    -NasdaqGS
    5.93 Up 0.03(0.51%) Dec 26, 4:00PM EST
    |After Hours : 5.97 Up 0.04 (0.67%) Dec 26, 4:50PM EST
    Add to Portfolio
    Prev Close:5.90
    Open:5.90
    Bid:5.85 x 1000
    Ask:N/A
    1y Target Est:8.93
    Beta:1.84
    Next Earnings Date:30-Jan-15IMGN Earnings announcement
    Day's Range:5.81 - 6.03
    52wk Range:5.34 - 17.80
    Volume:1,615,071
    Avg Vol (3m):1,682,640
    Market Cap:509.59M
    P/E (ttm):N/A
    EPS (ttm):-0.96
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMGN

    Comparison

    Symbol% ChgMkt Cap
    IMGNUp 0.51%509.59M
    PFEUp 0.73%199.42B
    RHHBYDown 0.16%232.56B
    SGENUp 2.89%3.96B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.07
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.70
    Quarterly EPS Est (Dec-14) :-0.06
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback